About Actimed
Pipeline
Cachexia
News & Events
Contact
NEWS
Apr 13, 2021
Actimed Therapeutics and Faraday Pharmaceuticals Announce License Agreement for S-oxprenolol
Feb 2, 2021
Actimed Therapeutics Appoints Frank Misselwitz MD, PhD as Chief Medical Officer
Management Team and Board
David Ebsworth
Chairman
Robin Bhattacherjee
Chief Executive Officer
Andrew J. Stewart Coats
Founder and Non-Executive Director
Frank Misselwitz
Chief Medical Officer and Non-executive Director
Stefan Wohlfeil
Non-executive Director
Hugh Jackson
Chief Financial Officer